(Image courtesy of Penumbra)
Penumbra (NYSE:PEN) announced today that the FDA has granted expanded clearance for its Indigo aspiration catheter system, Lightning 12.
Indigo Lightning is now indicated for the removal of fresh, soft emboli and thrombi from vessels of the peripheral arterial and venous systems as well as for the treatment of pulmonary embolism, according to the Alameda, Calif.-based company.
Get the full story on our sister site, Medical Tubing + Extrusion.
